Intrinsic Value of S&P & Nasdaq Contact Us

Acasti Pharma Inc. ACST NASDAQ

NASDAQ Capital Marke • Healthcare • Biotechnology • CA • USD

SharesGrow Score
40/100
1/5 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Stock Statistics — ACST

Acasti Pharma Inc. (ACST) has a market capitalization of $34.17M and trades at $3.37. The 52-week range is 1.98-3.6.

Key metrics include a trailing Price-to-Earnings (P/E) ratio of -4.3, Earnings Per Share (EPS) of $-0.79.

The stock has a beta of 1.52, operates in the Healthcare sector.

Trading Data
Current Price$3.37
52-Week Range1.98-3.6
Volume27.68K
Avg Volume (30D)33.25K
Market Cap$34.17M
Beta (1Y)1.52
Company
IPO Date2012-02-07
Employees32
CEOPrashant Kohli
CountryCA
ExchangeNASDAQ Capital Marke
CurrencyUSD
ISINCA00430K8656
CUSIP00430K402
Income (Latest Year)
Net Income$-12.77M
EPS$-0.79
EPS Diluted$-0.79
Shares Outstanding$12.09M
Balance Sheet (Latest Year)
Total Assets$71.99M
Current Assets$22.71M
Cash & ST Investments$22.13M
Total Liabilities$5.38M
Net Debt$-22.13M
Valuation Ratios
P/E Ratio-4.3
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message